Kozak & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ATO
Kozak & Associates's MRK Position: Q2 2026 in Review
Kozak & Associates reduced its Merck (MRK) stake by 4.7% in Q2 2026, selling an estimated $5.5K and leaving 951 shares worth $119K. The position accounts for 0.02% of the portfolio, ranked #98.
Kozak & Associates first reported a position in MRK in Q4 2020 and has held it in 21 quarters since. The position peaked at $502K in Q1 2024. 1,549 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Kozak & Associates held 951 shares of Merck worth $119K as of Q2 2026.
- Kozak & Associates sold 47 Merck shares in Q2 2026, an estimated $5.5K.
- Merck made up 0.02% of Kozak & Associates's portfolio in Q2 2026, its #98 holding.
- Kozak & Associates first reported a position in Merck in Q4 2020 and has held it in 21 quarters since.
- Kozak & Associates's Merck position peaked at $502K in Q1 2024.
- 1,549 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.